HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Correlation between negative expression of pepsinogen C and a series of phenotypic markers of gastric cancer in different gastric diseases.

Abstract
Gastric tumorigenesis is a multistep process initiated by chronic superficial gastritis (SG), followed by atrophic gastritis (AG), then intestinal metaplasia (IM), and finally by dysplasia and adenocarcinoma according to the Correa model. Pepsinogen C (PGC) decreases gradually during progression of cancer, which makes PGC an ideal negative marker for GC. To explore the correlation between PGC and other positive tumor markers in different gastric diseases, we observed the expression of PGC, MG7-Ag, MMP9, NM23, Ki-67, and E-cadherin by immunohistochemistry, quantitative RT-PCR, and immunoblot analysis. Our results showed that in SG, PGC was highly expressed while malignant phenotype markers were rarely expressed. In contrast with SG, malignant phenotype markers were highly expressed while the positive rate of PGC reached only 1.44% in GC. So there was no coexpression of PGC and malignant phenotype markers in SG or GC tissues. Only in the AG group, which is well-known to be gastric precancerous disease, coexpression of PGC and malignant phenotype markers was detected. Our results suggested that the expression of PGC in AG was negatively correlated with that of MG7-Ag and MMP9. Of all AG, those with low expression of PGC and high expression of MG7-Ag and MMP9 may possess a greater potential of malignant transformation. Combined detection of negative marker PGC and positive markers MG7-Ag and MMP9 could be used as a potential follow-up panel for monitoring dynamical progression of AG and improving the detection efficiency of high-risk individuals of gastric cancer, and then taking necessary interventions on the target population.
AuthorsJingyi Jiang, Shixuan Shen, Nannan Dong, Jingwei Liu, Qian Xu, Liping Sun, Yuan Yuan
JournalCancer medicine (Cancer Med) Vol. 7 Issue 8 Pg. 4068-4076 (08 2018) ISSN: 2045-7634 [Electronic] United States
PMID29963765 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2018 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Chemical References
  • Biomarkers
  • Biomarkers, Tumor
  • Pepsinogen C
Topics
  • Biomarkers
  • Biomarkers, Tumor
  • Cell Line
  • Female
  • Gene Expression
  • Humans
  • Immunohistochemistry
  • Male
  • Pepsinogen C (genetics, metabolism)
  • Phenotype
  • Retrospective Studies
  • Stomach Diseases (diagnosis, genetics, metabolism)
  • Stomach Neoplasms (diagnosis, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: